{"id":517507,"date":"2021-07-26T09:04:08","date_gmt":"2021-07-26T13:04:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/"},"modified":"2021-07-26T09:04:08","modified_gmt":"2021-07-26T13:04:08","slug":"ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/","title":{"rendered":"ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">RARITAN, N.J.<\/span>, <span class=\"xn-chron\">July 26, 2021<\/span> \/PRNewswire\/ &#8212; Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world&#8217;s largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX\u2122 Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected of an automated platform, is now available in <span class=\"xn-location\">Canada<\/span>.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1580457\/Ortho_Clinical_Diagnostics_ORTHO_OPTIX.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1580457\/Ortho_Clinical_Diagnostics_ORTHO_OPTIX.jpg\" title=\"When paired with the ORTHO\u2122 Workstation, the ORTHO OPTIX\u2122 Reader provides a complete semi-automated testing platform for transfusion labs with low- to mid-volume throughput.\" alt=\"When paired with the ORTHO\u2122 Workstation, the ORTHO OPTIX\u2122 Reader provides a complete semi-automated testing platform for transfusion labs with low- to mid-volume throughput.\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>When paired with the ORTHO\u2122 Workstation, the ORTHO OPTIX Reader provides a complete semi-automated testing platform for transfusion labs with low- to mid-volume throughput. The ORTHO OPTIX Reader has been shown to deliver 99.9% concordance<sup>1<\/sup>, demonstrated by the award-winning fully automated ORTHO VISION<sup>\u00ae<\/sup> Analyzer. The concordant and high-resolution images of the ORTHO OPTIX Reader help to support the technologist during remote review of results from across the laboratory. It also offers larger volume labs and health care networks a way to back-up or scale up their operations without having to invest in an additional full-automation analyzer.\u00a0 <\/p>\n<p>&#8220;We&#8217;re pleased to announce the launch of the ORTHO OPTIX Reader in <span class=\"xn-location\">Canada<\/span>, further demonstrating our commitment to provide continuous innovation and improvement in transfusion medicine to the Canadian market&#8221;, said <span class=\"xn-person\">Andrew Corkum<\/span>, Ortho&#8217;s head of transfusion medicine product portfolio. &#8220;The ORTHO OPTIX Reader allows every lab, regardless of size, workflow or throughput, the same high quality, standardized results consistent with our ORTHO VISION Analyzers without compromising quality and accuracy.&#8221;<\/p>\n<p>The ORTHO OPTIX Reader&#8217;s high-resolution camera captures color, grayscale, front and back images of each test without operator intervention, which provides objective data for automated results interpretation and eliminates the subjectivity and discrepancies associated with human reading of results. <\/p>\n<p>The ORTHO OPTIX Reader leverages the same proven ORTHO ID-MTS\u2122 Gel card Technology as the ORTHO VISION Analyzer and a comprehensive testing menu.<\/p>\n<p>When connected to the customer&#8217;s laboratory information system, column grades and images can be automatically sent for long-term retention of result interpretations, therefore reducing and\/or eliminating the need for manual documentation of results. The system audit log and reporting module enhances traceability and reporting capabilities to keep labs compliant with accreditations and regulations. It also utilizes best-in-class ID-MTS<span>\u2122<\/span> Gel Card technology which offers a comprehensive testing menu to help standardize lab practices. <\/p>\n<p>The ORTHO OPTIX Reader is now available in <span class=\"xn-location\">North America<\/span>.<\/p>\n<p>\n        <b>About Ortho Clinical Diagnostics<\/b>\n      <\/p>\n<p>Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world&#8217;s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care.<\/p>\n<p>More than 800,000 patients across the world are impacted by Ortho&#8217;s tests each day.\u00a0<i>Because Every Test is a Life<\/i><sup>TM<\/sup>, Ortho provides hospitals, hospital networks, clinical laboratories and blood banks around the world with innovative technology to ensure test results are fast, accurate, and reliable. Ortho&#8217;s customized solutions enhance clinical outcomes, improve efficiency, overcome lab staffing challenges and reduce costs.<\/p>\n<p>From launching the first product to determine Rh+ or Rh- blood type, developing the world&#8217;s first tests for the detection of antibodies against HIV and hepatitis C, introducing patented dry-slide technology and marketing the first U.S. Food and Drug Administration-authorized high-volume antibody and antigen tests for COVID-19, Ortho has been a pioneering leader in the IVD space for over 80 years. <\/p>\n<p>The company is powered by <span class=\"xn-person\">Ortho Care<\/span><sup>TM<\/sup>, an award-winning, holistic service and support program that ensures best-in-class technical, field and remote service and inventory support to laboratories in more than 130 countries and territories around the globe.\u00a0\u00a0<\/p>\n<p>For more information, visit\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3237746-1&amp;h=3776887149&amp;u=http%3A%2F%2Fwww.orthoclinicaldiagnostics.com%2F&amp;a=Ortho%27s+website%C2%A0\" rel=\"nofollow noopener\">Ortho&#8217;s website\u00a0<\/a>or social media\u00a0 channels:\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3237746-1&amp;h=2077735069&amp;u=https%3A%2F%2Fnam11.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fortho-clinical-diagnostics%26data%3D04%7C01%7Celaine.colon%40orthoclinicaldiagnostics.com%7Cd797453839894256df1f08d8d4eb1751%7C6e63ffc0c2fc4cc4b6c4666b2ce89d92%7C0%7C0%7C637493453465851706%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%7C1000%26sdata%3DgT69nWBCtC6mKpfMYOCKA4gpiq2SFt%252BISqGXqiqz%252BKM%253D%26reserved%3D0&amp;a=LinkedIn\" rel=\"nofollow noopener\">LinkedIn<\/a>,\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3237746-1&amp;h=441352809&amp;u=https%3A%2F%2Fnam11.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Ftwitter.com%252Forthoclinicaldx%253Flang%253Den%26data%3D04%7C01%7Celaine.colon%40orthoclinicaldiagnostics.com%7Cd797453839894256df1f08d8d4eb1751%7C6e63ffc0c2fc4cc4b6c4666b2ce89d92%7C0%7C0%7C637493453465861699%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%7C1000%26sdata%3Dk9ojndQcPacZd7w6VdoYBofxhAn9sdislKn0R7tx9WY%253D%26reserved%3D0&amp;a=Twitter\" rel=\"nofollow noopener\">Twitter<\/a>,\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3237746-1&amp;h=20778720&amp;u=https%3A%2F%2Fnam11.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.facebook.com%252FOrthoClinicalDX%252F%26data%3D04%7C01%7Celaine.colon%40orthoclinicaldiagnostics.com%7Cd797453839894256df1f08d8d4eb1751%7C6e63ffc0c2fc4cc4b6c4666b2ce89d92%7C0%7C0%7C637493453465871694%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%7C1000%26sdata%3DoQqcJmUhIvF03Xw9gK%252FeoKagz73yNb4Oi4NHlwsQ8Mg%253D%26reserved%3D0&amp;a=Facebook\" rel=\"nofollow noopener\">Facebook<\/a>\u00a0and\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3237746-1&amp;h=95214037&amp;u=https%3A%2F%2Fnam11.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.youtube.com%252Fchannel%252FUCWH7q_2wI_25OjHS3fcci8g%26data%3D04%7C01%7Celaine.colon%40orthoclinicaldiagnostics.com%7Cd797453839894256df1f08d8d4eb1751%7C6e63ffc0c2fc4cc4b6c4666b2ce89d92%7C0%7C0%7C637493453465871694%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%7C1000%26sdata%3DpMFaa9%252F4k%252FKKLPPF4ETFVJiLUgEK%252FCxn9xy5Ebb9Zjc%253D%26reserved%3D0&amp;a=YouTube\" rel=\"nofollow noopener\">YouTube<\/a>.\u00a0<\/p>\n<p>PR-11487<\/p>\n<p>\n        <sup>1<\/sup>\u00a0For direct and indirect antiglobulin testing, as determined by External Validation Testing using ID-MTS<sup>TM <\/sup>Gel Card Technology. The acceptance criteria for concordance for direct and indirect antiglobulin was \u226598.0% with a lower bound 95% CI of 99.87%.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY53069&amp;sd=2021-07-26\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada-301340389.html\">https:\/\/www.prnewswire.com\/news-releases\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada-301340389.html<\/a><\/p>\n<p>SOURCE  Ortho Clinical Diagnostics<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY53069&amp;Transmission_Id=202107260900PR_NEWS_USPR_____NY53069&amp;DateId=20210726\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire RARITAN, N.J., July 26, 2021 \/PRNewswire\/ &#8212; Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world&#8217;s largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX\u2122 Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected of an automated platform, is now available in Canada. When paired with the ORTHO\u2122 Workstation, the ORTHO OPTIX Reader provides a complete semi-automated testing platform for transfusion labs with low- to mid-volume throughput. The ORTHO OPTIX Reader has been shown to deliver 99.9% concordance1, demonstrated by the award-winning fully automated ORTHO VISION\u00ae Analyzer. The concordant and high-resolution images of the ORTHO OPTIX Reader help to support the technologist during remote review &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-517507","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire RARITAN, N.J., July 26, 2021 \/PRNewswire\/ &#8212; Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world&#8217;s largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX\u2122 Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected of an automated platform, is now available in Canada. When paired with the ORTHO\u2122 Workstation, the ORTHO OPTIX Reader provides a complete semi-automated testing platform for transfusion labs with low- to mid-volume throughput. The ORTHO OPTIX Reader has been shown to deliver 99.9% concordance1, demonstrated by the award-winning fully automated ORTHO VISION\u00ae Analyzer. The concordant and high-resolution images of the ORTHO OPTIX Reader help to support the technologist during remote review &hellip; Continue reading &quot;ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-26T13:04:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1580457\/Ortho_Clinical_Diagnostics_ORTHO_OPTIX.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada\",\"datePublished\":\"2021-07-26T13:04:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\\\/\"},\"wordCount\":629,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1580457\\\/Ortho_Clinical_Diagnostics_ORTHO_OPTIX.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\\\/\",\"name\":\"ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1580457\\\/Ortho_Clinical_Diagnostics_ORTHO_OPTIX.jpg\",\"datePublished\":\"2021-07-26T13:04:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1580457\\\/Ortho_Clinical_Diagnostics_ORTHO_OPTIX.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1580457\\\/Ortho_Clinical_Diagnostics_ORTHO_OPTIX.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/","og_locale":"en_US","og_type":"article","og_title":"ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada - Market Newsdesk","og_description":"PR Newswire RARITAN, N.J., July 26, 2021 \/PRNewswire\/ &#8212; Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world&#8217;s largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX\u2122 Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected of an automated platform, is now available in Canada. When paired with the ORTHO\u2122 Workstation, the ORTHO OPTIX Reader provides a complete semi-automated testing platform for transfusion labs with low- to mid-volume throughput. The ORTHO OPTIX Reader has been shown to deliver 99.9% concordance1, demonstrated by the award-winning fully automated ORTHO VISION\u00ae Analyzer. The concordant and high-resolution images of the ORTHO OPTIX Reader help to support the technologist during remote review &hellip; Continue reading \"ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-26T13:04:08+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1580457\/Ortho_Clinical_Diagnostics_ORTHO_OPTIX.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada","datePublished":"2021-07-26T13:04:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/"},"wordCount":629,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1580457\/Ortho_Clinical_Diagnostics_ORTHO_OPTIX.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/","name":"ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1580457\/Ortho_Clinical_Diagnostics_ORTHO_OPTIX.jpg","datePublished":"2021-07-26T13:04:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1580457\/Ortho_Clinical_Diagnostics_ORTHO_OPTIX.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1580457\/Ortho_Clinical_Diagnostics_ORTHO_OPTIX.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ORTHO OPTIX\u2122 Reader Completes Transfusion Medicine Portfolio, Now Available in Canada"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517507","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=517507"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517507\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=517507"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=517507"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=517507"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}